We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


The Rise of Companion Diagnostics

The Rise of Companion Diagnostics content piece image

Companion Diagnostics can identify patients who are most likely to benefit from a particular therapeutic, highlight those at increased risk for serious side effects as a result of treatment with a particular therapeutic, and monitor treatment response to a particular therapeutic.

Since the approval of Herceptin® in 1998, companion diagnostics have played a vital role in the safe and effective use of a corresponding drug.

Learn more about companion diagnostics including:

  • the growth in the market
  • the technologies used
  • the challenges and benefits
  • the future